EMEA Solid Oral Nutraceutical Excipient Market, By Functionality (Binders, Fillers & Diluents, Suspension & Viscosity Agents, Coatings, Disintegrants, and Others), Formulation (Tablets, Capsules, Gummies, and Others), End Product (Probiotics, Prebiotics, Protein and Amino Acid Supplements, Vitamin Supplements, Mineral Supplements, Omega-3 Supplements, and Other Supplements), Excipient Source (Synthetic and Natural), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, Italy, U.K., France, Spain, Belgium, Netherlands, Russia, Switzerland, Turkey, rest of Europe, South Africa, Saudi Arabia, U.A.E., Algeria, Oman, Kuwait, and rest of Middle East and Africa) - Industry Trends and Forecast to 2031.
EMEA Solid Oral Nutraceutical Excipient Market Analysis and Insights
The EMEA solid oral nutraceutical excipient market has witnessed steady growth in recent years, driven by increasing consumer awareness of health and wellness, rising demand for dietary supplements, and pharmaceutical and nutraceutical formulation advancements. Excipients are crucial in developing solid oral dosage forms, influencing nutraceutical products' stability, bioavailability, and overall performance.
Key factors contributing to the market growth include the expanding aging population, the growing health-conscious consumer base, and the surge in lifestyle-related health issues, which has fueled the demand for nutritional supplements. Regulatory initiatives and standards in the EMEA region also play a vital role in shaping the market landscape, with manufacturers focusing on compliance with quality and safety regulations.
However, the market faces challenges such as stringent regulatory requirements and the need for continuous innovation.
The EMEA solid oral nutraceutical excipient market is expected to gain market growth in the forecast period of 2024 to 2031. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.6% in the forecast period of 2024 to 2031 and is expected to reach USD 443,498.11 thousand by 2031 from USD 269,272.69 thousand in 2023.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Thousand and Volume in Units
|
|
Segments Covered
|
By Functionality (Binders, Fillers & Diluents, Suspension & Viscosity Agents, Coatings, Disintegrants, and Others), Formulation (Tablets, Capsules, Gummies, and Others), End Product (Probiotics, Prebiotics, Protein and Amino Acid Supplements, Vitamin Supplements, Mineral Supplements, Omega-3 Supplements, and Other Supplements), Excipient Source (Synthetic and Natural), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
Germany, Italy, U.K., France, Spain, Belgium, Netherlands, Russia, Switzerland, Turkey, rest of Europe, South Africa, Saudi Arabia, U.A.E., Algeria, Oman, Kuwait, and rest of Middle East and Africa
|
|
Market Players Covered
|
Ingredion, azelis, JRS Pharma, BASF Corporation, Omya, Ashland, DuPont, Sigachi Industries, International Flavors & Fragrances Inc., Croda International Plc, Cargill, Incorporated., Grain Processing Corporation, Kerry Group plc, Roquette Frères, Colorcon, Bioground GmbH, BENEO (A subsidiary of Südzucker AG), Evonik Industries AG, and SEPPIC among others
|
EMEA Solid Oral Nutraceutical Excipient Market Definition
Solid oral nutraceutical excipients are non-active substances strategically incorporated into the formulation of nutritional products in dosage forms, such as tablets or capsules, to fulfill various functional roles. These excipients play a pivotal role in the overall product development process, contributing to the final nutraceutical product's physical attributes, manufacturability, and performance.
EMEA solid oral nutraceutical excipient market Dynamics
Drivers
- Increasing Demand for Nutraceuticals
Consumers are turning to nutraceutical items as preventive healthcare and increased health consciousness become more prevalent. These functional foods and supplements are considered good for resolving certain health issues, completing dietary gaps, and improving general health. The EMEA region's aging population is a factor in the rise in nutraceutical consumption. The products that assist bone health, cognitive function, healthy aging, and other age-related issues are becoming increasingly popular as people get older.
Consumer demands for new and useful nutraceutical products that fuel the demand for innovative excipients that facilitate formulation innovation. The stabilization, bioavailability, and transport of the active substances in these products are all improved by using excipients. Excipients must align with the nutraceutical industry's trend towards natural ingredients and clean labelling. Excipients from natural sources or those deemed safe and hygienic are sought after by manufacturers to incorporate into their goods.
- Rising Advancements in Nutraceuticals Excipients
The need for excipients who can help formulate and deliver these nutraceuticals more effectively is growing while this research is expanding. In nutraceutical products, excipients play a crucial role in guaranteeing active ingredients' stability, bioavailability, and efficacy. Their role is crucial in converting research results into feasible and commercially viable formulations. Nutraceuticals are gaining fresh insights into their health-promoting qualities through scientific studies, clinical trials, and ongoing research endeavors to determine their efficacy, safety, and possible applications.
Thus, the rising research activities based on nutraceuticals is expected to act as a driver for the market growth.
Opportunity
- Growing Health Awareness Among the Population
People are more inclined to look for functional meals, vitamins, and supplements that meet their demands for wellbeing as a result of this increased awareness. The demand for nutraceutical products has increased as a result, and their formulation calls for safe and efficient excipients. The market potential is increased by the growing interest in health supplements. Excipient makers now have a larger consumer base and the chance to innovate and create excipients that specifically cater to the needs of these health-conscious consumers.
There is an increase in demand for nutraceutical items such as vitamins, functional foods, and dietary supplements due to a greater emphasis on wellness and preventive healthcare. These products frequently have solid oral dose forms, which means that good excipients must be used in the formulation process. When purchasing nutraceutical items, health-conscious consumers are looking for a variety of specialized formulations.
Challenges/ Restraints
- Regulatory Compliance for Nutraceuticals Excipients
The complexities stem from the necessity of adhering to various regulatory structures in these areas. Each EMEA nation may have its own set of regulations regarding acceptable concentrations, safety evaluations, acceptable excipients, and labelling specifications. Companies that operate internationally find it difficult to navigate this regulatory environment since it necessitates a thorough awareness of several regulatory frameworks and the resources to modify operations and goods accordingly. The regular updates and modifications further increase the difficulty to legislation. It takes constant adaptation to keep up with changing standards, which can tax resources and cause delays in product development and market launch. This regulatory load raises the risk of non-compliance, which could have expensive consequences and limit market access, and lengthen the time and expense of bringing products to market.
- Risk of Product Liability and Safety Concerns
Although excipients are essential parts of nutraceutical formulations, their safety is very important. Excipient-related adverse reactions or safety concerns may result in product recalls, harm to a brand's reputation, and legal ramifications for the makers. Worries about product liability and safety might damage consumer confidence. Unfavorable events, including documented adverse effects or safety-related disputes involving nutraceutical goods, can greatly influence customer perception, lowering demand and fostering mistrust in the industry. Product liability concerns may give rise to litigation, court cases, and monetary fines. The stability and profitability of excipient manufacturers might be negatively impacted by the significant costs associated with settling disputes or defending against legal claims.
Any quality variation, safety concerns, or unfavorable reactions associated with these excipients may result in serious consequences.
Recent Developments
- In October 2023, Evonik Industries AG introduced a functioning, ready-to-fill oral capsule for preclinical studies. The 9-hour (5.1 mm) EUDRACAP preclinic enteric capsule is a technical-grade capsule that is small enough to fit through the gastrointestinal system of preclinical animal models
- In July 2023, Evonik Industries AG and Heraeus Precious Metals will increase the variety of services both businesses offer for highly powerful active pharmaceutical ingredients (HPAPIs).The collaboration offers clients a fully integrated solution that spans pre-clinical research through commercial manufacture by combining the unique hpapi capabilities of both businesses
EMEA Solid Oral Nutraceutical Excipient Market Scope
The EMEA solid oral nutraceutical excipient market is categorized into five notable segments based on functionality, formulation, end product, excipient source, and distribution channel.The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Functionality
- Binders
- Fillers & diluents
- Suspension & viscosity agents
- Coatings
- Disintegrants
- Others
On the basis of functionality, the market is segmented into binders, fillers & diluents, suspension & viscosity agents, coatings, disintegrants, and others.
Formulation
- Tablets
- Capsules
- Gummies
- Others
On the basis of formulation, the market is segmented into tablets, capsules, gummies, and others.
End Product
- Probiotics
- Prebiotics
- Protein and Amino Acid Supplements
- Vitamin Supplements
- Mineral Supplements
- Omega-3 Supplements
- Other Supplements
On the basis of end product, the market is segmented into probiotics, prebiotics, protein and amino acid supplements, vitamin supplements, mineral supplements, omega-3 supplements, and other supplements.
Excipient Source
- Synthetic
- Natural
On the basis of excipient source, the market is segmented into synthetic and natural.
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.
EMEA Solid Oral Nutraceutical Excipient Market : Regional Analysis/Insights
The EMEA solid oral nutraceutical excipient market is categorized into five notable segments such as functionality, formulation, end product, excipient source, and distribution channel.
The countries covered in this market report Germany, Italy, U.K., France, Spain, Belgium, Netherlands, Russia, Switzerland, Turkey, rest of Europe, South Africa, Saudi Arabia, U.A.E., Algeria, Oman, Kuwait, and rest of Middle East and Africa.
Germany is expected to dominate the market in the Europe region due to the strong presence of market players in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of EMEA brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Share Analysis: EMEA Solid Oral Nutraceutical Excipient Market
EMEA solid oral nutraceutical excipient market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, product type lifeline curve. The above data points provided are only related to the company’s focus on the EMEA solid oral nutraceutical excipient market.
Some of the major players operating in the EMEA solid oral nutraceutical excipient market are Ingredion, azelis, JRS Pharma, BASF Corporation, Omya, Ashland, DuPont, Sigachi Industries, International Flavors & Fragrances Inc., Croda International Plc, Cargill, Incorporated., Grain Processing Corporation, Kerry Group plc, Roquette Frères, Colorcon, Bioground GmbH, BENEO (A subsidiary of Südzucker AG), Evonik Industries AG, and SEPPIC among others.
SKU-